Narayana Hrudayalaya Limited Wins NCLT Sanction for Clinic Demerger

Narayana Hrudayalaya Limited received NCLT sanction on October 30, 2026, for the demerger of 10 clinics from wholly owned subsidiary NH Integrated Care Private Limited, with no new shares to be issued and no change expected in its shareholding pattern. The order advances the internal transfer of the clinical services business into the listed healthcare company.

What did the NCLT sanction for Narayana Hrudayalaya Limited?

The National Company Law Tribunal, Bengaluru Bench, sanctioned a Scheme of Arrangement between Narayana Hrudayalaya Limited and NH Integrated Care Private Limited. Under the scheme, the Clinical Services undertaking of NH Integrated Care will be demerged and transferred to Narayana Hrudayalaya Limited on a going-concern basis.

NH Integrated Care is a wholly owned subsidiary of Narayana Hrudayalaya Limited. The company said the undertaking includes nine clinics in Bengaluru and one clinic in Hosur. The tribunal's order is dated October 30, 2026, while the appointed date specified in the scheme is April 1, 2025.

The sanctioned arrangement is an internal restructuring rather than an acquisition involving an outside party. The listed parent will bring the clinic business directly under its operations after the scheme becomes effective. Narayana Hrudayalaya Limited operates a network of 55 healthcare facilities in India and also has a presence in the Cayman Islands and the United Kingdom.

How did the demerger proposal receive approval?

The proposal moved through board, exchange, shareholder, creditor and tribunal processes before receiving the NCLT sanction. Narayana Hrudayalaya Limited's board approved the scheme on December 12, 2025, under Sections 230 to 232 of the Companies Act, 2013.

The NCLT's February 13, 2026 order directed the company to convene meetings of equity shareholders, secured creditors and unsecured creditors. Those meetings were held on April 2, 2026 through video conferencing or other audio-visual means. Voting results submitted on April 3, 2026 showed near-unanimous support across all three classes.

Equity shareholders approved the scheme with 99.9999% votes in favour. The votes in favour represented 16,19,59,684 votes, while 79.25% of the equity share capital participated in the poll. Secured creditors and unsecured creditors each gave 100% approval based on the claims represented by participating creditors.

The approval process also included exchange-level observations before the tribunal proceedings. The supplied disclosures state that BSE issued a no-adverse-observations letter on June 23, 2025, followed by an NSE no-objection letter on June 24, 2025 for the proposed scheme.

What are the key figures in the Narayana Hrudayalaya Limited scheme?

The key figures show that the transaction is limited to the transfer of 10 clinics and does not require consideration through an issue of Narayana Hrudayalaya Limited shares. Creditor support covered secured claims of ₹838.09 crore and unsecured claims of ₹371.30 crore.

The company has stated that neither its share capital nor its shareholding pattern is expected to change because NH Integrated Care is already wholly owned. This distinguishes the arrangement from a merger in which shareholders of a transferor company receive shares in the transferee company.

When will the scheme become effective?

The scheme will become effective only after the certified copy of the NCLT order is filed with the Registrar of Companies by both NH Integrated Care and Narayana Hrudayalaya Limited. The effective date will be the later of the two filing dates.

Narayana Hrudayalaya Limited said a copy of the NCLT order had been shared for information, while the certified copy was still awaited. Therefore, the tribunal sanction is a major approval milestone, but the legal transfer of the undertaking depends on the prescribed Registrar of Companies filings.

The distinction between the appointed date and the effective date matters for the scheme's implementation. April 1, 2025 is the appointed date specified in the arrangement, whereas the operational effectiveness of the tribunal-sanctioned transfer is linked to the completion of the statutory filing process.

Why does the clinic transfer matter to investors and operations?

The scheme consolidates the clinical services undertaking of NH Integrated Care within Narayana Hrudayalaya Limited, the listed parent. Since the business is being transferred on a going-concern basis, the disclosed arrangement is designed to place the clinics directly within the parent entity rather than discontinue their activities.

For investors, the company has explicitly stated that there will be no issue of new shares, no change in share capital and no change in the shareholding pattern. This means the disclosed structure does not involve equity dilution for existing shareholders. The supplied information does not provide separate revenue, profit, asset or valuation figures for the transferred clinics, so the immediate financial contribution of the undertaking cannot be quantified from these disclosures.

The strong creditor and shareholder voting outcomes provide evidence of formal stakeholder support for the restructuring. However, the next legal step remains the filing of certified copies of the tribunal order with the Registrar of Companies. The company has not disclosed a specific completion date for those filings.

Conclusion

Narayana Hrudayalaya Limited has secured NCLT approval to absorb the clinical services undertaking of its wholly owned subsidiary, NH Integrated Care Private Limited. The arrangement covers 10 clinics, received 99.9999% equity shareholder approval and unanimous approval from the participating secured and unsecured creditor classes. Its structure avoids a share issue because the subsidiary is already fully owned by the listed parent.

Investors should watch for confirmation that both entities have filed certified copies of the NCLT order with the Registrar of Companies, which will make the scheme effective. Subsequent disclosures on the integration of the clinics and any separate financial information relating to the transferred undertaking would offer further clarity on the operational effect of the restructuring.